Mallinckrodt Loses $9.5M Award, Wins Delay In Airgas Drug
A Delaware federal judge on Tuesday threw out Mallinckrodt Pharmaceuticals' $9.5 million jury award it won in an infringement case and instead blocked a competitor's inhaled nitric oxide treatment patent until... (more story)
Karyopharm OK To Borrow $25M In Fast-Track Ch. 11 Case
Cancer drug developer Karyopharm Therapeutics Inc. on Tuesday secured a Texas bankruptcy judge's approval to borrow $25 million in Chapter 11 financing and solicit bids for its business, as the company looks t... (more story)
Healthcare REITs Funnel Billions Into Senior Housing In Q3
The two biggest healthcare real estate investment trusts in the U.S., Welltower Inc. and Ventas Inc., have invested a combined $26 billion this year in buying senior housing for their respective portfolios, as... (more story)
MVP: Dudensing Law's Ed Dudensing
Ed Dudensing of Dudensing Law won a $110 million verdict in a case involving a dementia victim at a private equity-backed senior housing facility and a separate $15.75 million total jury verdict in a neglected... (more story)
Law360 MVP Awards Go To Top Attorneys From 89 Firms
The lawyers chosen as Law360's 2026 MVPs stand out from their peers by notching significant achievements in high-stakes litigation, complex global matters and record-setting transactions.
Teva, AbbVie To Face Trial Over Niaspan Pay-For-Delay Claims
Long-running multidistrict litigation over AbbVie and Teva Pharmaceuticals' agreement to delay generic forms of cholesterol drug Niaspan is headed toward trial, after a Pennsylvania federal judge Friday found ... (more story)